Greenwich LifeSciences share price logo

Greenwich LifeSciences

NASDAQ: GLSI

$15.97

+0.23

(+1.46%)

Live

as on

Greenwich LifeSciences Stock Performance

as on September 4, 2026 at 2:07 am IST

  • Day's Low

    Day's High

    $15.62
    $16.00
    downward going graph

    2.19%

    Downside

    0.19%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.78
    $34.10
    downward going graph

    51.28%

    Downside

    113.53%

    Upside

    downward going graph

Greenwich LifeSciences share price movements today

Previous Close
$15.74
Open
$15.65
Volume
19.9K
Market Cap
$220.3M
Day's Low - High
$15.62 - $16.00
52 Week Low - High
$7.78 - $34.10

Greenwich LifeSciences Historical Returns

1 Month Return
+ 11.19 %
3 Month Return
-38.21 %
1 Year Return
+ 30.98 %
3 Year Return
+ 62.62 %
5 Year Return
-66.25 %

Greenwich LifeSciences Stock Fundamentals & Key Indicators

Check Greenwich LifeSciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$220.3M

EPS (TTM)

-1.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.75

Industry PE ratio

-1.4626335877862595

PEG Ratio

0.7453851463557652

EBITDA

-21.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-793.76%

Greenwich LifeSciences Stock Valuation

Track how Greenwich LifeSciences P/E has moved over time to understand its valuation trends.

Greenwich LifeSciences in the last 5 years

  • Overview

  • Trends

Lowest (-68.90x)

December 31, 2021

Today (-14.69x)

December 31, 2025

Industry (-1.46x)

December 31, 2025

Highest (-9.28x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -14.69x

Greenwich LifeSciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Greenwich LifeSciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$220.3M-66.25%-9.750.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Greenwich LifeSciences Stock including INR - Dollar returns

The Greenwich LifeSciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Greenwich LifeSciences investment value today

Current value as on today

₹1,49,484

Returns

₹49,484

(+49.48%)

Returns from Greenwich LifeSciences Stock

₹39,354 (+39.35%)

Dollar Impact

₹10,130 (+10.13%)

Analyst Recommendation on Greenwich LifeSciences Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Greenwich LifeSciences. Average target price of $57

Greenwich LifeSciences Share Price Target

Get share price movements and forecasts by analysts on Greenwich LifeSciences.

What analysts predicted

71.98%UPSIDE

Target Price

$57

Current Price

$15.97

Analyzed by

2 Analysts

Target

$57.00

Greenwich LifeSciences target price $57, a slight upside of 71.98% compared to current price of $15.97. According to 2 analysts rating.

Indian Investors' Interest in Greenwich LifeSciences Stock

Search interest for Greenwich LifeSciences Stock has increased by 279% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:279% versus previous 30 day period

Greenwich LifeSciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
-
-
-
-
Operating Income
-2
-2
-2
-8
-2
-4
-4
-7
-5
-4
EBITDA
-2
-2
-2
-8
-2
-4
-4
-7
-5
-3
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
-
-
-
0
Income Before Tax
-2
-2
-2
-8
-2
-4
-4
-7
-5
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-2
-8
-2
-4
-4
-7
-5
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Greenwich LifeSciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-3
-1
-4
-8
-9
-17
-19
EBITDA
-1
-1
-3
-1
-4
-7
-8
-17
-19
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-3
-1
-4
-7
-8
-17
-19
Income Tax Expense
0
-
-
-
-
-
-
-
-
Net Income
-1
-1
-3
-1
-4
-7
-8
-17
-19
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Greenwich LifeSciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-2
-2
-8
-3
-4
-4
-7
-5
-3
Operating Cash Flow
-1
-1
-2
-1
-1
-2
-2
-3
-4
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
2
1
0
0
2
3
5
9
0
Change in Cash
-1
1
-1
-1
-1
0
0
2
4
-1

Greenwich LifeSciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-1
-3
-1
-4
-7
-8
-15
-19
Operating Cash Flow
0
0
0
-1
-4
-6
-6
-7
-9
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
29
2
-7
-
4
11
Change in Cash
0
0
0
28
-1
-13
-6
-2
2

Mutual Funds that own Greenwich LifeSciences Stock

Check out the Mutual Funds with significant holdings in Greenwich LifeSciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.977775%
290302
Fidelity Concord Street Trust
0.466119%
68418
Fidelity Salem Street Trust
0.464988%
68252
VANGUARD SCOTTSDALE FUNDS
0.25343%
37199
RUSSELL INVESTMENT CO
0.121493%
17833

Global Institutional Holdings in Greenwich LifeSciences

Funds
Holdings
Invesco
0.01%
Vanguard
2.58%
iShares
1.82%
SPDR
0.25%
Goldman Sachs
0.06%

Greenwich LifeSciences News & Key Events

    Insights on Greenwich LifeSciences

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, GLSI has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 490.6%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, GLSI stock has moved down by -16.0%

    About Greenwich LifeSciences

    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States. Its lead product candidate is GP2, a HER2/neu transmembrane peptide, which is in Phase III clinical trial to prevent breast cancer recurrences in patients. The company also develops FLAMINGO-01, which is in Phase IIb and 3 Phase I clinical trial designed to evaluate the safety and efficacy of GLSI-100 in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
    OrganisationGreenwich LifeSciences
    HeadquartersBuilding 14, Stafford, TX, United States, 77477
    IndustryBiotechnology
    CEOMr. Snehal S. Patel
    E-voting on sharesClick here to vote

    Key Management of Greenwich LifeSciences

    Name

    Title

    Mr. Snehal S. Patel

    CEO, CFO & Director

    Mr. Eric Rothe

    Founder & Independent Director

    Dr. Frank Joseph Daugherty M.D.

    Chief Medical Officer & Director

    Dr. Jaye L. Thompson Ph.D.

    Vice President Clinical & Regulatory Affairs

    Dr. Christine T. Fischette Ph.D.

    VP of Business Development

    FAQs

    What is Greenwich LifeSciences share price today?

    Greenwich LifeSciences share price today is $15.97 as on . Greenwich LifeSciences share today touched a day high of $16.00 and a low of $15.62.

    What is the 52 week high and 52 week low for Greenwich LifeSciences share?

    Greenwich LifeSciences share touched a 52 week high of $34.10 on and a 52 week low of $7.78 on . Greenwich LifeSciences stock price today i.e. is trending at $15.97,which is 53.17% down from its 52 week high and 105.27% up from its 52 week low.

    What is Greenwich LifeSciences's market capitalisation today?

    Greenwich LifeSciences market capitalisation is $0.00T as on .

    How to invest in Greenwich LifeSciences Stock (GLSI) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Greenwich LifeSciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Greenwich LifeSciences Shares that will get you 0.0939 shares as per Greenwich LifeSciences share price of $15.97 per share as on September 3, 2026 at 8:37 pm IST.

    What is the minimum amount required to buy Greenwich LifeSciences Stock (GLSI) from India?

    Indian investors can start investing in Greenwich LifeSciences (GLSI) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹944.75 in Greenwich LifeSciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Greenwich LifeSciences share’s latest price of $15.97 as on September 3, 2026 at 8:37 pm IST, you will get 0.6262 shares of Greenwich LifeSciences. Learn more about fractional shares .

    What are the returns that Greenwich LifeSciences has given to Indian investors in the last 5 years?

    Greenwich LifeSciences stock has given -66.25% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?